Pfizer India Share Price Target Tomorrow 2024 To 2030- Current Graph, Market Overview

Pfizer Ltd is the Indian subsidiary of the global pharmaceutical giant, Pfizer Inc. The company is known for producing a wide range of medicines and vaccines that address various health conditions, from chronic diseases to infectious illnesses. Pfizer has a strong presence in India, with a focus on innovation and high-quality healthcare solutions. Pfizer India Share Price on NSE as of 4 October 2024 is 5,614.05 INR. Here will provide you more details on Pfizer India Share Price Target 2024, 2025, 2026 to 2030.

Pfizer Ltd: Market Overview

• Open Price: ₹5,570.00
• High Price: ₹5,766.00
• Low Price: ₹5,560.00
• Previous Close: ₹5,484.75
• Volume: 186,588
• Value (Lacs): ₹10,479.53
• VWAP: 5,660.75
• UC Limit: ₹6,581.70
• LC Limit: ₹4,387.80
• P/E ratio: 42.21
• Div yield: 0.62%
• 52-wk high: ₹6,451.15
• 52-wk low: ₹3,838.00
• Mkt cap: ₹25.68KCr
• Face Value: ₹10

Pfizer Ltd Competitors

Here are three competitors of Pfizer Ltd along with their approximate market capitalizations:

1. GlaxoSmithKline Pharmaceuticals Ltd (GSK)
   • Market Capital: ₹46,000 crore
     GSK is a major player in the pharmaceutical industry, offering a wide range of products, including vaccines and medicines, competing with Pfizer in several therapeutic areas.
2. Cipla Ltd
   • Market Capital: ₹100,000 crore
     Cipla is a leading Indian pharmaceutical company with a strong presence in generics and branded formulations, making it a key competitor to Pfizer.

3. Dr. Reddy’s Laboratories Ltd

   • Market Capital: ₹95,000 crore
     Dr. Reddy’s Laboratories is a global pharmaceutical company, known for its generics and active pharmaceutical ingredients, posing competition to Pfizer in various markets.

Pfizer India Share Price Chart

Pfizer India Share Price Target Tomorrow 2024 To 2030

Pfizer India Share Price Target 2024

Pfizer India share price target 2024 Expected target could be ₹6375. Here are three key factors that could influence the growth of Pfizer India’s share price target in 2024:

• Product Pipeline and Approvals: Pfizer India’s ability to launch new drugs, vaccines, or receive regulatory approvals for innovative treatments will significantly impact its share price. Success in expanding its portfolio will likely boost investor confidence and drive growth.
• Market Demand for Vaccines and Pharmaceuticals: Ongoing demand for COVID-19 vaccines, along with medicines for chronic diseases like diabetes, cancer, and cardiovascular conditions, could contribute to strong revenue growth and support share price appreciation.

• Regulatory and Policy Changes: Any favorable changes in Indian healthcare policies or regulations related to pharmaceutical pricing, patents, or drug approvals could create growth opportunities, positively affecting Pfizer India’s stock performance.

Pfizer India Share Price Target 2025

Pfizer India share price target 2025 Expected target could be ₹7293. Here are three key factors that could influence the growth of Pfizer India’s share price target in 2025:

• Expansion into New Therapeutic Areas: If Pfizer India expands its presence in high-growth areas like oncology, rare diseases, or advanced biologics, it could lead to increased revenues and a higher share price. Strategic partnerships or acquisitions in these sectors will also play a vital role.
• Healthcare Infrastructure and Access: The Indian government’s focus on improving healthcare infrastructure and increasing access to medicines may boost demand for Pfizer’s products. Enhanced distribution networks and access to rural markets can drive growth and share price gains.

• Global Market Trends and Export Growth: Pfizer India’s ability to tap into global markets, leveraging Pfizer’s global R&D and distribution channels, could lead to increased exports. Global demand for generic versions of Pfizer’s drugs and vaccines might also contribute to strong financial performance and stock appreciation in 2025.

Pfizer India Share Price Target 2030

Pfizer India share price target 2030 Expected target could be ₹14316. Here are three potential risks and challenges that could impact Pfizer India’s share price target in 2030:

1. Regulatory and Compliance Issues: Changes in healthcare regulations, pricing controls, and stricter compliance standards by the Indian government or international markets could affect Pfizer India’s profit margins, making it harder to meet share price growth expectations.
2. Generic Competition: Pfizer India faces the challenge of increasing competition from local and international generic drug manufacturers. As patents expire, the rise of low-cost alternatives could reduce market share and put pressure on pricing.

3. R&D Investment and Innovation: The company’s ability to consistently innovate and bring new drugs to market is crucial for long-term growth. If Pfizer India struggles with high R&D costs or delays in developing breakthrough treatments, it could impact revenue growth and investor confidence by 2030.

Pfizer Ltd Shareholding Pattern

• Promoter: 63.9%
• FII: 3.2%
• DII: 15.8%
• Public: 17%

Pfizer Ltd Financials

Read Also:- CreditAccess Grameen Share Price Target Tomorrow 2024 To 2030 and More Details